Abstract
BackgroundLung cancers are the leading cause of cancer-related deaths globally and have a 5-year survival of ~20%. Whilst immunotherapies have led to durable and prolonged survival, only a subset of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
